Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice

Leukemia Research

Volumn 20, Issue 11-12, 1996, Pages 941-946

  Singhal, Seema ^a,b   Vourka Karussis, Urania ^b   Mehta, Jayesh ^a,b   Slavin, Shimon ^b   Weiss, Lola ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Autologous graft vs host disease; BALB c mice; BCL1 murine leukemia; Cyclosporine; Graft vs host disease; Graft vs leukemia; Immunotherapy; Interleukin 2; SJL J mice

Indexed keywords

CYCLOSPORIN; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; INTRAPERITONEAL DRUG ADMINISTRATION; ISOGRAFT; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; LEUKEMIA, B-CELL; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; RADIATION CHIMERA; T-LYMPHOCYTE SUBSETS; WHOLE-BODY IRRADIATION;

EID: 0030293933     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00064-1     Document Type: Article

References (30)

1. 1. Kersey J. H., Weisdorf D., Nesbit M. E., Lellien T. W., Woods W. G., McGlave P. B., Kim T., Vallera D. A., Goldman A. I., Bostrom B., Hurd D. & Ramsay N. K. C. (1987) Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N. Engl. J. Med. 317, 461.
2. 2. Weiden P. L., Flournoy N., Thomas E. D., Prentice R., Fefer A., Buckner C. D. & Storb R. (1979) Antileukemic effect of graft-vs-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 300, 1068.
3. 3. Weiden P. L., Sullivan K. M., Flournoy N., Storb R. & Thomas E. D. (1981) Antileukemic effect of chronic graft-vs-host disease: contribution to improved survival after allogeneic, marrow transplantation. N. Engl. J. Med. 304, 1529.
4. 4. Slavin S., Ackerstein A., Naparstek E., Or R. & Weiss L. (1990) The graft-vs-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transpl. 6, 155.
5. 5. Truitt R. L. & Atasoylu A. A. (1991) Impact of pretransplant conditioning and donor T cells on chimerism, graft-vs-host disease, graft-vs-leukemia reactivity, and tolerance after bone marrow transplantation. Blood 77, 2515.
6. 6. Weiss L., Weigensberg M., Morecki S., Bar S., Cobbold S., Waldmann H. & Slavin S. (1990) Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia. Cancer Immunol. Immunother. 31, 236.
7. 7. Meredith R. F. & Okunewick J. P. (1983) Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation. Transplantation 35, 378.
8. 8. Kasid A., Morecki S., Aebersold P., Cornetta K., Culver K., Freeman S., Director E., Lotze M. T., Blaese R. M., Anderson W. F. & Rosenberg S. A. (1990) Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc. natn. Acad. Sci. USA 87, 473.
9. 9. George A. J. T. & Stevenson F. K. (1989) Prospects for the treatment of B cell tumours using idiotypic vaccination. Intl Rev. Immunol. 4, 271.
10. 10. Rappeport J., Mihm M., Reinherz E., Lopansri S. & Parkman R. (1979) Acute graft-vs-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet 2, 717.
11. 11. Glazier A., Tuttschka P. J., Farmer E. R. & Santos G. W. (1983) Graft-vs-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J. Expl Med. 158, 1.
12. 12. Beschorner W. E., Shinn C. A., Fischer A. C., Santos G. W. & Hess A. D. (1988) Cyclosporine-induced pseudograft-vs-host disease in the early post-cyclosporine period. Transplantation 46, 112S.
13. 13. Cheney R. T. & Sprent J. (1985) Capacity of cyclosporine to induce auto-graft-vs-host disease and impair intrathymic T cell differentiation. Transpl. Proc. 17, 528.
14. 14. Chow L. H., Mosbach Ozmen L., Ryffel B. & Borel J. F. (1988) Syngeneic graft-vs-host disease induced by cyclosporine - a reappraisal. Transplantation 46, 107S.
15. 15. Jones R. L. Jr, Vogelsang G. B., Hess A. D., Farmer E. R., Mann R. B., Geller R. B., Piantadosi S. & Santos G. W. (1989) Induction of graft-vs-host disease after autologous bone marrow transplantation. Lancet 1, 754.
16. 16. Rizzoli V., Carella A. M., Carlo-Stella C. & Mangoni L. (1990) Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group. Bone Marrow Transpl. 6, Suppl 1, 76.
17. 17. Yeager A. M., Vogelsang G. B., Jones R.L, Farmer E. R., Altomonte V., Hess A. D. & Santos G. W. (1992) Induction of cutaneous graft-vs-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 79, 3031.
18. 18. Mehta J. (1993) Graft-vs-leukemia reactions in clinical bone marrow transplantation. Leuk. Lymph. 10, 427.
19. 19. Geller R. B., Esa A. H., Beschorner W. E., Frondoza C. G., Santos G. W. & Hess A. D. (1989) Successful in vitro graft-vs-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-vs-host disease in the rat. Blood 74, 1165.
20. 20. Talbot D. C., Powles R. L., Sloane J. P., Rose J., Treleaven J., Aboud H., Helenglass G., Parikh P., Smith C., Rowley M., Cavanagh J. & Milliken S. (1990) Cyclosporine-induced graft-vs-host disease following autologous bone marrow transplantation in acute myeloid leukaemia. Bone Marrow Transpl. 6, 17.
21. 21. Kennedy M. J., Vogelsang G. B., Beveridge R. A., Farmer E. R., Altomonte V., Huelskamp A. M. & Davidson N. E. (1993) Phase I trial of intravenous cyclosporine to induce graft-vs-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. Clin. Oncol. 11, 478.
22. 22. Slavin S. & Strober S. (1978) Spontaneous murine B-cell leukemia 1. Nature 272, 624.
23. 23. Harris M. R., Kindle C. S., Abruzzini A. F., Pierce C. W. & Cullen S. E. (1984) Antigen presentation by the BCL1 murine B cell line: in vitro stimulation by LPS. J. Immunol. 133, 1202.
24. 24. Slavin S., Weiss L., Morecki S., Ben-Bassat H., Leizerowitz R., Gamliel H., Korkesh A., Voss R. & Polliack A. (1981) Ultrastructural, cell membrane, and cytogenetic: characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia. Cancer Res. 41, 4162.
25. 25. Resnitzky P., Estrov Z. & Haran-Ghera N. (1985) High incidence of acute myeloid leukemia in SJL/J mice after X-irradiation and corticosteroids. Leukemia Res. 9, 1519.
26. 26. Trakhtenbrot L., Krauthgamer R., Resnitzky P. & Haran-Ghera N. (1988) Deletion of chromosome 2 is an early event in the development of radiation-induced myeloid leukemia in SJL/J mice. Leukemia 2, 545.
27. 27. Cohen P., Vourka-Karussis U., Weiss L. & Slavin S. (1993) Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor-and host-specific alloantigens. J. Immunol. 151, 4803.
28. 28. Vourka-Karussis U., Karussis D., Ackerstein A. & Slavin S. (1995) Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice. Expl Hematol. 23, 196.
29. 29. Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringden O., Rozman C., Speck B., Truitt R. L., Zwaan F. E. & Bortin M. M. (1990) Graft-vs-leukemia reactions after bone marrow transplantation. Blood 75, 555.
30. 30. Weiss L., Reich S. & Slavin S. (1990) Effect of cyclosporine A and methylprednisolone on the graft-vs-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation. Bone Marrow Transpl. 6, 229.